Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study-Reference-Cited by-同舟云学术

Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study

Published:2016-07-06 Issue:5 Volume:41 Page:499-502
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Samuel S.¹,Allison T. A.¹,Sharaf S.¹,Yau G.¹,Ranjbar G.¹,Mckaig N.¹,Nguyen A.²,Escobar M.³,Choi H. A⁴

Affiliation:

1. Department of Pharmacy; Memorial Hermann - Texas Medical Center; Houston TX USA

2. Department of Pathology and Laboratory Medicine; The University of Texas Medical School at Houston; Houston TX USA

3. Department of Hematology; The University of Texas Medical School at Houston; Houston TX USA

4. Department of Neurosurgery and Neurology; The University of Texas Medical School at Houston; Houston TX USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12415/fullpdf

Reference18 articles.

1. Challenges in variation and responsiveness of unfractionated heparin;Francis;Pharmacotherapy,2004

2. Monitoring unfractionated heparin with the aPTT: time for a fresh look;Eikelboom;Thromb Haemost,2006

3. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy;Olson;Arch Pathol Lab Med,1998

4. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time;Basu;N Engl J Med,1972

5. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Hirsh;Chest,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of C-reactive Protein on Anticoagulation Monitoring in Extracorporeal Membrane Oxygenation;Journal of Cardiothoracic and Vascular Anesthesia;2024-09

2. Evaluating the Use of Unfractionated Heparin with Intra-Aortic Balloon Counterpulsation;Heart, Lung and Circulation;2024-07

3. Clinical guidance for unfractionated heparin dosing and monitoring in critically ill patients;Expert Opinion on Pharmacotherapy;2024-05-23

4. Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation;Seminars in Thrombosis and Hemostasis;2024-05-11

5. ECMO in Obstetrics;Critical Care Obstetrics;2024-04